574 related articles for article (PubMed ID: 15856183)
21. Role of non-selective adenosine receptor blockade and phosphodiesterase inhibition in cisplatin-induced nephrogonadal toxicity in rats.
Saad SY; Najjar TA; Alashari M
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):862-7. PubMed ID: 15659050
[TBL] [Abstract][Full Text] [Related]
22. Acute CdMT injection is not a good model to study chronic Cd nephropathy: comparison of chronic CdCl2 and CdMT exposure with acute CdMT injection in rats.
Liu J; Habeebu SS; Liu Y; Klaassen CD
Toxicol Appl Pharmacol; 1998 Nov; 153(1):48-58. PubMed ID: 9875299
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical localizations of secretin, cholecystokinin, and somatostatin in the rat small intestine after acute cisplatin treatment.
Miyamoto Y; Miyamoto M
Exp Mol Pathol; 2004 Dec; 77(3):238-45. PubMed ID: 15507242
[TBL] [Abstract][Full Text] [Related]
24. Cisplatin nephrotoxicity and protection by silibinin.
Gaedeke J; Fels LM; Bokemeyer C; Mengs U; Stolte H; Lentzen H
Nephrol Dial Transplant; 1996 Jan; 11(1):55-62. PubMed ID: 8649653
[TBL] [Abstract][Full Text] [Related]
25. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
[TBL] [Abstract][Full Text] [Related]
26. Assessment of the possible role of iron and copper in cisplatin-induced nephrotoxicity in the rat.
Goudie J; Chandra M; Lawrence GD; Williams P
Res Commun Chem Pathol Pharmacol; 1994 Jan; 83(1):33-49. PubMed ID: 8165368
[TBL] [Abstract][Full Text] [Related]
27. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
[TBL] [Abstract][Full Text] [Related]
28. In vivo biochemical indices of nephrotoxicity of platinum analogs tetraplatin, CHIP, and cisplatin in the Fischer 344 rat.
Smith MA; Smith JH; Litterst CL; Copley MP; Uozumi J; Boyd MR
Fundam Appl Toxicol; 1988 Jan; 10(1):62-72. PubMed ID: 3350230
[TBL] [Abstract][Full Text] [Related]
29. Role of ellagic acid against cisplatin-induced nephrotoxicity and oxidative stress in rats.
Ateşşahín A; Ceríbaşi AO; Yuce A; Bulmus O; Cikim G
Basic Clin Pharmacol Toxicol; 2007 Feb; 100(2):121-6. PubMed ID: 17244261
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of novel biomarkers of nephrotoxicity in two strains of rat treated with Cisplatin.
Gautier JC; Riefke B; Walter J; Kurth P; Mylecraine L; Guilpin V; Barlow N; Gury T; Hoffman D; Ennulat D; Schuster K; Harpur E; Pettit S
Toxicol Pathol; 2010 Oct; 38(6):943-56. PubMed ID: 20716785
[TBL] [Abstract][Full Text] [Related]
31. Protective effects of vitamin C on cisplatin-induced renal damage: a light and electron microscopic study.
Tarladacalisir YT; Kanter M; Uygun M
Ren Fail; 2008; 30(1):1-8. PubMed ID: 18197536
[TBL] [Abstract][Full Text] [Related]
32. Differential effects of tannic acid on cisplatin induced nephrotoxicity in rats.
Tikoo K; Bhatt DK; Gaikwad AB; Sharma V; Kabra DG
FEBS Lett; 2007 May; 581(10):2027-35. PubMed ID: 17470369
[TBL] [Abstract][Full Text] [Related]
33. Cisplatin induced damage in kidney genomic DNA and nephrotoxicity in male rats: the protective effect of grape seed proanthocyanidin extract.
Saad AA; Youssef MI; El-Shennawy LK
Food Chem Toxicol; 2009 Jul; 47(7):1499-506. PubMed ID: 19351554
[TBL] [Abstract][Full Text] [Related]
34. Acute and chronic cisplatin nephropathy in rats.
Choie DD; Longnecker DS; del Campo AA
Lab Invest; 1981 May; 44(5):397-402. PubMed ID: 7194946
[TBL] [Abstract][Full Text] [Related]
35. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
[TBL] [Abstract][Full Text] [Related]
36. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
Osman NM; Copley MP; Litterst CL
Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
[TBL] [Abstract][Full Text] [Related]
37. Disparity in actions of rosiglitazone against cisplatin-induced nephrotoxicity in female Sprague-Dawley rats.
Kumar P; Prashanth KS; Gaikwad AB; Vij M; Barua CC; Bezbaruah B
Environ Toxicol Pharmacol; 2013 Nov; 36(3):883-90. PubMed ID: 24001946
[TBL] [Abstract][Full Text] [Related]
38. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085
[TBL] [Abstract][Full Text] [Related]
39. Direct amifostine effect on renal tubule cells in rats.
Weichert-Jacobsen KJ; Bannowski A; Küppers F; Loch T; Stöckle M
Cancer Res; 1999 Jul; 59(14):3451-3. PubMed ID: 10416609
[TBL] [Abstract][Full Text] [Related]
40. Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats.
Atessahin A; Yilmaz S; Karahan I; Ceribasi AO; Karaoglu A
Toxicology; 2005 Sep; 212(2-3):116-23. PubMed ID: 15946783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
